SMAD3 and breast carcinoma: Prior studies indicate that circRNAs can modulate the TGF-β/SMAD pathway in breast cancer (BCa) [38], with circRIP2 notably expediting BCa progression via the miR-1305/TGF-β2/smad3 pathway [35, 37, 38].